Is tumor necrosis factor-α friend or foe for chronic heart failure?

Circulation Research

Volumn 113, Issue 5, 2013, Pages 492-494

  Hori, Masatsugu ^a   Yamaguchi, Osamu ^b  

^a OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; INTERLEUKIN 1BETA; INTERLEUKIN 6; MANGANESE SUPEROXIDE DISMUTASE; MYOSIN HEAVY CHAIN ALPHA; NITRIC OXIDE SYNTHASE; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

CARDIOVASCULAR MORTALITY; CELL DAMAGE; CELL REGENERATION; COMPLEMENT ACTIVATION; CONGESTIVE HEART FAILURE; EXTRACELLULAR MATRIX; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; INNATE IMMUNITY; LEUKOCYTE MIGRATION; MECHANICAL STRESS; MYOCARDITIS; NOTE; PHENOTYPE; PLEURA EFFUSION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TISSUE SURVIVAL;

ANIMALS; ANTIBODIES, MONOCLONAL; HEART FAILURE; HISTORY, 20TH CENTURY; MICE; MICE, TRANSGENIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84883316333     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.113.302024     Document Type: Note

References (18)

1. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;323:236-241
2. Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O. Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation. 1995;92:1479-1486
3. Testa M, Yeh M, Lee P, Fanelli R, Loperfido F, Berman JW, LeJemtel TH. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 1996;28:964-971
4. Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-a. Circ Res. 1997;81:627-635
5. Kubota T, McTiernan CF, Frye CS, Demetris AJ, Feldman AM. Cardiacspecific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. J Card Fail. 1997;3:117-124
6. Mann DL, McMurray JJ, Packer M, et al. Targeted anticytokine therapy in patients with chronic heart failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL). Circulation. 2004;109:1594-1602
7. Chung ES, Packer M, Lo KH, Fasanmade AA, Willerson JT; Anti-TNF Therapy Against Congestive Heart Failure Investigators. Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: Results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial. Circulation. 2003;107:3133-3140
8. Gordon JW, Shaw JA, Kirshenbaum LA. Multiple facets of NF-?B in the heart: To be or not to NF-?B. Circ Res. 2011;108:1122-1132
9. Baetz D, Regula KM, Ens K, Shaw J, Kothari S, Yurkova N, Kirshenbaum LA. Nuclear factor-kappaB-mediated cell survival involves transcriptional silencing of the mitochondrial death gene BNIP3 in ventricular myocytes. Circulation. 2005;112:3777-3785
10. Hikoso S, Yamaguchi O, Nakano Y, et al. The I{kappa}B kinase {beta}/ nuclear factor {kappa}B signaling pathway protects the heart from hemodynamic stress mediated by the regulation of manganese superoxide dismutase expression. Circ Res. 2009;105:70-79
11. O'Donnell SM, Hansberger MW, Connolly JL, et al. Organ-specific roles for transcription factor NF-kappaB in reovirus-induced apoptosis and disease. J Clin Invest. 2005;115:2341-2350
12. Mann DL. Inflammatory mediators and the failing heart: Past, present, and the foreseeable future. Circ Res. 2002;91:988-998
13. Piccinini AM, Midwood KS. DAMPening inflammation by modulating TLR signalling. Mediators Inflamm. 2010;doi:10.1155/2010/672395
14. Marchant DJ, Boyd JH, Lin DC, Granville DJ, Garmaroudi FS, McManus BM. Inflammation in myocardial diseases. Circ Res. 2012;110:126-144
15. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol. 2001;1:135-145
16. Oka T, Hikoso S, Yamaguchi O, Taneike M, Takeda T, Tamai T, Oyabu J, Murakawa T, Nakayama H, Nishida K, Akira S, Yamamoto A, Komuro I, Otsu K. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature. 2012;485:251-255
17. Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L. Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol. 1999;83:376-382
18. Van Deventer SJH. Transmembrane TNF-a, induction of apoptosis, and the efficacy of TNF-targeting therapies in Crohn's Disease. Gastroentherology. 2001;121;1242-1245